natgillin/translations-raw huggingface dataset:
A second or repeat dose when seizures re-occur after an initial response should not be given without prior medical advice (see section 5.2). 
Drugega odmerka ali ponavljajočega se odmerka pri ponovitvi epileptičnega napada po začetnem odzivu ne smete dati brez predhodnega zdravniškega nasveta (glejte poglavje 5.2).
Your doctor will prescribe the appropriate dose of BUCCOLAM your child needs, generally according to your child's age. 
Zdravnik vam bo predpisal pravilni odmerek zdravila BUCCOLAM, ki ga potrebuje vaš otrok, na splošno glede na bolnikovo starost.
Children younger than 3 months: BUCCOLAM should not be given to children younger than 3 months since there is not enough information in this age group. 
Otroci, mlajši od 3 mesecev: Zdravila BUCCOLAM ne dajajte otrokom, mlajšim od 3 mesecev, ker za to starostno skupino ni dovolj informacij.
Even though small amounts of BUCCOLAM may pass into breast milk, it may not be necessary to stop breast-feeding. 
Čeprav lahko majhne količine zdravila BUCCOLAM prehajajo v materino mleko, morda ne bo potrebno prenehati dojiti.
Altered elimination of midazolam 
Spremenjeno izločanje midazolama
If the child is having a seizure, allow their body to move freely, do not try to restrain them. 
Če ima otrok epileptični napad, mu pustite, da se telo prosto premika, ne poskušajte mu preprečevati gibanja.
Respiratory depression occurs at a rate of up to 5%, although this is a known complication of convulsive seizures as well as being related to midazolam use. 
Respiratorna depresija se je pojavila s stopnjo do 5 %, čeprav je to znani zaplet konvulzijskih napadov, ki je hkrati povezan z uporabo midazolama.
Using the finger and thumb gently pinch and pull back the child's cheek. 
S palcem in kazalcem nežno primite in potegnite nazaj otrokovo lice.
Paediatric patients aged 3 to 6 months 
Pediatrični bolniki, stari 3 mesece do 6 mesecev
• If the seizure does not stop within 10 minutes, call an ambulance. 
• Če epileptični napad v 10 minutah ne mine, pokličite reševalce.
Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness: 
Znotraj vsake skupine pogostnosti so neželeni učinki navedeni po padajoči resnosti:
Concomitant use with other benzodiazepines 
Sočasna uporaba z drugimi benzodiazepini
Tell your doctor or pharmacist if the patient is taking, or has recently taken, or might take any other medicines. 
Obvestite svojega zdravnika ali farmacevta, če bolnik jemlje, je pred kratkim jemal ali pa bo morda začel jemati katero koli drugo zdravilo.
If in any doubt, call for immediate medical help if: 
Če niste gotovi, pokličite takojšnjo medicinsko pomoč, če:
The bioavailability of oromucosal midazolam has been estimated at 87% in children with severe malaria and convulsions. 
Biološka uporabnost oralnega midazolama je bila ocenjena pri 87 % otrok s težko malarijo in konvulzijami.
• An allergy to midazolam, benzodiazepines (such as diazepam) or any of the other ingredients of this medicine (listed in section 6) 
• alergijo na midazolam, benzodiazepine (kot je diazepam) ali katero koli sestavino tega zdravila (navedeno v poglavju 6);
This medicine may cause people to forget what happened after they have been given it. 
To zdravilo lahko povzroči, da bolniki ne vedo, kaj se je z njimi dogajalo, potem ko so prejeli to zdravilo.
BUCCOLAM with food and drink 
Zdravilo BUCCOLAM skupaj s hrano in pijačo
This medicine may also stop some other medicines from working as well, e.g. levodopa (used to treat Parkinson's disease). 
To zdravilo lahko tudi prepreči delovanje nekaterih drugih zdravil, npr. levodope (ki se uporablja za zdravljenje Parkinsonove bolezni).
Giving high doses of BUCCOLAM during the last 3 months of pregnancy can cause abnormal heart beat in the unborn child. 
Dajanje velikih odmerkov zdravila BUCCOLAM v zadnjih 3 mesecih nosečnosti lahko povzroči nenormalen srčni utrip pri nerojenem otroku.
E.g. baclofen. 
Npr. baklofen.
The absolute bioavailability of oromucosal midazolam is about 75% in adults. 
Absolutna biološka razpoložljivost oralnega midazolama je pri odraslih približno 75 %.
The safety and efficacy of midazolam in children aged 0 to 3 months has not been established. 
Pediatrična populacija Varnost in učinkovitost midazolama pri otrocih, starih 0 do 3 mesece, nista dokazani.
What BUCCOLAM is and what it is used for What you need to know before you give BUCCOLAM How to give BUCCOLAM 
Kaj je zdravilo BUCCOLAM in za kaj ga uporabljamo Kaj morate vedeti, preden boste dali zdravilo BUCCOLAM Kako dati zdravilo BUCCOLAM
The European Medicines Agency has waived the obligation to submit the results of studies with BUCCOLAM in the subset of the paediatric population < 3months old, on the grounds that the specific medicinal product does not represent a significant therapeutic benefit over existing treatments for these paediatric patients. 
Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom BUCCOLAM za vse skupine pediatrične populacije < 3 mesece starosti, saj to zdravilo ne kaže značilnih terapevtskih koristi glede na obstoječa zdravljenja teh pediatričnih bolnikov.
Antiepileptics 
Antiepileptiki
What BUCCOLAM is and what it is used for 
Kaj je zdravilo BUCCOLAM in za kaj ga uporabljamo
3 to 6 months hospital setting 
3 do 6 mesecev bolnišnica
Signs may include chest pain which may spread to the child's neck and shoulders and down their left arm. 
Med znaki so lahko bolečina v prsih, ki se lahko razširi v otrokov vrat in rame in po levici navzdol.
Ask a doctor, pharmacist or nurse to show you how to take or administer this medicine. 
Prosite zdravnika, farmacevta ali medicinsko sestro, naj vam pokaže, kako se zdravilo jemlje ali daje.
• antihistamines (to treat allergies). 
• antihistaminiki (za zdravljenje alergij).
Midazolam decreases the minimum alveolar concentration (MAC) of inhalation anaesthetics. 
Midazolam zmanjša minimalno alveolarno koncentracijo (MAC) inhalacijskih anestetikov.
Each syringe is for single use only. 
Vsaka brizga je samo za enkratno uporabo.
Exposure following a second dose in the same seizure episode Simulated exposure data show that the overall AUC approximately doubles when a second dose is administered at 10, 30 and 60 minutes following the first dose. 
Simulirani podatki o izpostavljenosti kažejo, da se celokupni AUC približno podvoji, če damo drugi odmerek 10, 30 ali 60 minut po prvem.
Label colour 
Barva oznake
No data on exposed pregnancies are available for the first two trimesters of pregnancy. 
Za prvi dve trimesečji nosečnosti ni podatkov o izpostavljenosti med nosečnostjo.
The effects of BUCCOLAM may be reduced by medicines such as: 
Učinke zdravila BUCCOLAM lahko zmanjšajo zdravila, kot so:
In 4 rectal diazepam controlled studies and one study versus intravenous diazepam, in a total of 688 children, cessation of visible signs of seizures within 10 minutes was observed in 65% to 78% of children receiving oromucosal midazolam. 
V 4 študijah kontroliranih z rektalno apliciranim diazepamom in v eni študiji kontrolirani z intravenskim diazepamom pri skupaj 688 otrocih so v roku 10 minut opazili prenehanje vidnih znakov epileptičnega napada pri 65 % do 78 % otrok, ki so oralno prejeli midazolam.
The elimination half-life in patients with chronic renal failure is similar to that in healthy volunteers. 
Razpolovna doba izločanja pri bolnikih s kronično odpovedjo ledvic je podobna kot pri zdravih prostovoljcih.
In a population pharmacokinetic study, the metabolite levels are shown to be higher in younger than older paediatric patients and thus likely to be of more importance in children than in adults. 
V farmakokinetičnih študijah populacije so bile ravni presnovkov višje pri mlajših kot pri starejših pediatričnih bolnikih, zato so verjetno pomembnejše za otroke kot za odrasle.
Midazolam is highly lipophilic and distributes extensively. 
Midazolam je zelo lipofilen in se obširno porazdeli.
An updated RMP should be submitted: - At the request of the European Medicines Agency; - 2Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached. 
− na zahtevo Evropske agencije za zdravila; ob vsakršni spremembi sistema za obvladovanje tveganj, zlasti kadar je tovrstna sprememba posledica prejema novih informacij, ki lahko privedejo do znatne spremembe razmerja med koristmi in tveganji, ali kadar je ta sprememba posledica tega, da je bil dosežen pomemben mejnik (farmakovigilančni ali povezan z zmanjševanjem tveganja).
Babies born after this medicine is administered during childbirth can also have poor suckling, breathing difficulties and poor muscle tone at birth. 
Otroci, ki se rodijo po dajanju tega zdravila med porodom, lahko pri rojstvu slabo sesajo, imajo težave z dihanjem in slab mišični tonus.
Alcohol (including alcohol-containing medicinal products may markedly enhance the sedative effect of midazolam. 
Alkohol (vključno z zdravili, ki vsebujejo alkohol), lahko znatno okrepi sedativni učinek midazolama.
Special attention should be paid to respiratory and cardiovascular functions in intensive care. 
Posebno pozornost je treba pri intenzivni negi posvetiti dihalnim in kardiovaskularnim funkcijam.
• A disease of the nerves and muscles causing muscle weakness (myasthenia gravis) 
• bolezen živcev in mišic, ki povzroča oslabelost mišic (miastenijo gravis);
• Reduced alertness 
• zmanjšana pozornost;
The different doses each have a different colour, which is shown on the carton, the tube and the syringe containing the medicine. 
Različni odmerki imajo vsak določeno barvo, ki je vidna na ovojnini, plastičnem ovitku in brizgi, ki vsebuje zdravilo.
This is due to an increase of approximately 50% in the volume of distribution corrected for total body weight. 
To je posledica zvišanja porazdelitvenega volumna za približno 50 %, korigiranega za skupno telesno maso.
• antifungals, e.g. ketoconazole, voriconazole, fluconazole, itraconazole, pozaconazole 
• antimikotiki, npr. ketokonazol, vorikonazol, flukonazol, itrakonazol, posakonazol,
How to give this medicine 
Kako dajemo to zdravilo
Given the higher metabolite to parent drug ratio in younger children, a delayed respiratory depression as a result of high active metabolite concentrations in the 3-6 months age group cannot be excluded. 
Zaradi visokega razmerja presnovkov glede na izhodiščno zdravilo pri majhnih otrocih zakasnele respiratorne depresije kot posledice visoke koncentracije aktivnih presnovkov v skupini 3-6 mesecev ni mogoče izključiti.
Each oral syringe is individually packed in a protective plastic tube. 
Vsaka brizga za peroralno dajanje je individualno pakirana v zaščitnem plastičnem ovitku.
PHARMACEUTICAL FORM Oromucosal solution Clear colourless solution pH 2.9 to 3.7 
FARMACEVTSKA OBLIKA oralna raztopina bistra brezbarvna raztopina pH 2,9 do 3,7
If the patient who will be given this medicine is pregnant or breast-feeding, thinks she may be pregnant or is planning to have a baby, ask a doctor for advice before taking this medicine. 
Če je bolnica, ki bo zdravilo dobila, noseča ali če doji, če meni, da bi lahko bila noseča, oziroma če načrtuje nosečnost, se posvetujte z zdravnikom, preden bo vzela to zdravilo.
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Strength 2.5 mg: 
B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Jakost 2,5 mg
Animal studies do not indicate a teratogenic effect with respect to reproductive toxicity, but foetotoxicity has been observed in humans as with other benzodiazepines. 
Študije na živalih ne kažejo na teratogeno delovanje glede sposobnosti razmnoževanja, vendar so, tako kakor že pri drugih benzodiazepinih, pri ljudeh opazili fetotoksičnost.
Animal studies did not show an impairment of fertility (see section 5.3). 
Študije na živalih niso pokazale vpliva na sposobnost razmnoževanja (glejte poglavje 5.3).
Common: ≥ 1/100 to < 1/10 
≥ 1/100 do < 1/10
Medical history of alcohol or drug abuse 
Anamneza zlorabe alkohola ali mamil
NAME OF THE MARKETING AUTHORISATION HOLDER Shire logo 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Logotip Shire
Following overdose with oral midazolam, vomiting should be induced (within one hour) if the patient is conscious or gastric lavage undertaken with the airway protected if the patient is unconscious. 
Po prevelikem odmerjanju oralnega midazolama je treba izzvati bruhanje (v roku ene ure), če je bolnik pri zavesti, ali izprati želodec ob zaščitenih dihalnih poteh, če je bolnik nezavesten.
A second dose at 10 minutes results in a significant increase in mean Cmax of between 1.7 to 1.9 fold. 
Prejem drugega odmerka po 10 minutah povzroči znatno povečanje povprečnega Cmax v razponu med 1,7- do 1,9-krat.
Pull the red cap off the tip of the syringe and dispose of it safely. 
Potegnite rdeči pokrovček s konice brizge in ga varno zavrzite.
BUCCOLAM is not for intravenous use. 
Zdravilo BUCCOLAM ni za intravensko uporabo.
Midazolam may cause anterograde amnesia. 
Midazolam lahko povzroči anterogradno amnezijo.
• An illness causing frequent interruption of breathing during sleep (sleep apnoea syndrome) 
• bolezen, ki povzroči pogosto prekinitev dihanja med spanjem (sindrom spalne apneje);
Published clinical studies show that oromucosal midazolam was administered to approx 443 children with seizures. 
Objavljene klinične študije kažejo, da so oralni midazolam dajali približno 443 otrokom z epileptičnimi napadi.
This may affect their performance at skilled tasks such as driving, riding a bicycle, or using machines. 
To lahko vpliva na njegovo sposobnost upravljanja vozil, vožnje s kolesom ali uporabe strojev.
After receiving this medicine, the patient should not drive a vehicle, ride a bicycle or operate a machine until they have completely recovered. 
Po apliciranju tega zdravila bolnik ne sme voziti avtomobila ali kolesa ali upravljati s stroji, dokler povsem ne okreva.
Small quantities of midazolam are found in human milk. 
V mleku najdemo majhne količine midazolama.
Check that the medicine is the correct dose for your child, according to their age. 
Prepričajte se, da imate glede na otrokovo starost pravilen odmerek zdravila za otroka.
Slowly press the syringe plunger until the plunger stops. 
Počasi pritiskajte na bat brizge, dokler se ne ustavi.
The basic nitrogen in position 2 of the imidazobenzodiazepine ring system enables midazolam to form the hydrochloride salt with acids. 
Bazični dušik na 2. mestu obročnega sistema imidazobenzodiazepina omogoča midazolamu, da s kislinami tvori hidrokloridne soli.
Overdose of benzodiazepines is usually manifested by degrees of central nervous system depression ranging from drowsiness to coma. 
Preveliko odmerjanje benzodiazepinov se običajno kaže s stopnjami depresije osrednjega živčevja, ki segajo od dremavosti do kome.
Syringe volume 
Volumen brizge
Alcohol intake should be strongly avoided in case of midazolam administration (see section 4.4). 
Uživanju alkohola se je treba pri dajanju midazolama močno izogibati (glejte poglavje 4.4).
After oromucosal administration, only systemic clearance will be affected. 
Po oralni uporabi je prizadet le sistemski očistek.
Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). 
Zdravljenje dalj časa trajajočih, akutnih epileptičnih napadov pri dojenčkih, malčkih, otrocih in mladostnikih (od starosti 3 mesecev do < 18 let).
Talk to your doctor or pharmacist about medicines the patient should avoid whilst taking BUCCOLAM. 
Posvetujte se z zdravnikom ali s farmacevtom o zdravilih, ki se jim mora bolnik izogibati, medtem ko jemlje zdravilo BUCCOLAM.
The major fraction of plasma protein binding is due to albumin. 
Največji del vezave na beljakovine plazme pripisujemo albuminu.
Midazolam overdose can present a threat to life if the patient has pre-existing respiratory or cardiac insufficiency, or when combined with other CNS depressants (including alcohol). 
Preveliki odmerki midazolama lahko ogrožajo življenje, če ima bolnik obstoječo respiratorno ali srčno insuficienco, ali v kombinaciji z drugimi depresorji osrednjega živčevja (vključno z alkoholom).
Examples include opiate derivatives (used as analgesics, antitussives or substitutive treatments), antipsychotics, other benzodiazepines used as anxiolytics or hypnotics, barbiturates, propofol, ketamine, etomidate; sedative antidepressants, non-recent H1-antihistamines and centrally acting antihypertensive medicinal products. 
Primeri vključujejo derivate opija (uporabljajo se kot analgetiki, antitusiki ali za nadomestno zdravljenje), antipsihotike, druge benzodiazepine, ki se uporabljajo kot anksiolitiki ali hipnotiki, barbiturate, propofol, ketamin, etomidat; sedativne antidepresive, starejše generacije H1
If necessary (for larger volumes and/or smaller patients), approximately half the dose should be given slowly into one side of the mouth, then the other half given slowly into the other side. 
Po potrebi (za večje volumne in/ali manjše bolnike) lahko polovico odmerka počasi vbrizgate na eno stran ust, nato pa drugo polovico na drugo stran.
Calcium-channel blockers 
Blokatorji kalcijevih kanalčkov
Debilitated patients are more prone to the central nervous system (CNS) effects of benzodiazepines and, therefore, lower doses may be required. 
Oslabeli bolniki so bolj dovzetni za učinke benzodiazepinov na osrednje živčevje, zato bodo morda potrebni manjši odmerki.
Sedation, somnolence, depressed levels of consciousness Respiratory depression 
Pogosti: sedacija, somnolenca, zmanjšana raven zavedanja, respiratorna depresija
• Severe difficulty breathing at rest (BUCCOLAM can make breathing difficulties worse) 
• velike težave z dihanjem med mirovanjem (zdravilo BUCCOLAM lahko dihanje še oteži);
In the management of overdose with any medicinal product, it should be borne in mind that multiple agents may have been taken. 
Zdravljenje Pri obravnavanju prevelikega odmerka kakršnegakoli zdravila je treba pomisliti na možnost, da je oseba zaužila različna zdravila.
If you have any doubt about whether any medicine the patient is taking may affect the use of BUCCOLAM, please speak to your doctor or pharmacist. 
Če ste negotovi, ali lahko katero od zdravil, ki ga jemlje bolnik, vpliva na uporabo zdravila BUCCOLAM, se pogovorite s svojim zdravnikom ali s farmacevtom.
What BUCCOLAM looks like and contents of the pack 3 months to less than 1 year: 2.5 mg - yellow labelled packaging 1 year to less than 5 years: 5 mg - blue labelled packaging 5 years to less than 10 years: 7.5 mg - purple labelled packaging 10 years to less than 18 years: 10 mg - orange labelled packaging 
Izgled zdravila BUCCOLAM in vsebina pakiranja 3 mesece do manj kot 1 leto: 2,5 mg - rumeno označeno pakiranje, 1 leto do manj kot 5 let: 5 mg - modro označeno pakiranje, 5 let do manj kot 10 let: 7,5 mg - vijolično označeno pakiranje, 10 let do manj kot 18 let: 10 mg - oranžno označeno pakiranje.
The elimination half-life of midazolam is prolonged up to six times in the critically ill. 
Razpolovna doba izločanja midazolama se pri kritično bolnih podaljša za do šestkrat.
There are no or limited amount of data from the use of midazolam in pregnant women. 
Podatkov o uporabi midazolama pri nosečnicah ni oziroma so omejeni.
4.5 Interaction with other medicinal products and other forms of interaction Midazolam is metabolized by CYP3A4. 
4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Midazolam presnavlja CYP3A4.
Other medicines and BUCCOLAM 
Druga zdravila in zdravilo BUCCOLAM
Alcohol may increase the sedative effects of this medicine and make them very sleepy. 
Alkohol lahko okrepi sedativne učinke tega zdravila in bolnika naredi zelo zaspanega.
After receiving midazolam, the patient should be warned not to drive a vehicle or operate a machine until completely recovered. 
Bolnika je treba po prejemu midazolama opozoriti, da naj ne vozi in ne upravlja s stroji, dokler povsem ne okreva.
• Muscle spasms and muscle tremors (shaking of your muscles that you cannot control) 
• mišični spazmi in mišični tremor (trzanje mišic, ki ga ne bolnik more nadzirati);
10 years to < 18 years Orange 
10 let do < 18 let oranžna
Laryngo-tracheal insertion should be avoided to prevent accidental aspiration of the solution. 
Preprečite laringotrahealno vstavitev, da ne pride do nezgodne aspiracije raztopine.
The other ingredients are sodium chloride, water for injections, hydrochloric acid and sodium hydroxide (for pH adjustment). 
Druge sestavine zdravila so natrijev klorid, voda za injekcije, klorovodikova kislina in natrijev hidroksid (za uravnavanje pH).
These produce a stable solution suitable for oromucosal administration. 
Tako nastane stabilna raztopina, primerna za oralno apliciranje.
The free base is a lipophilic substance with low solubility in water. 
Prosta baza je lipofilna snov z nizko vodotopnostjo.
• A lung condition that causes difficulty breathing on a regular basis. 
• bolezen pljuč, ki povzroča stalno oteženo dihanje.
BUCCOLAM is contraindicated in patients with severe hepatic impairment (see section 4.3). 
Zdravilo BUCCOLAM je kontraindicirano pri bolnikih s hudo okvaro jeter (glejte poglavje 4.3).
Do not give BUCCOLAM if the patient has: 
Bolniku ne dajajte zdravila BUCCOLAM, če ima:
BUCCOLAM is available in cartons containing 4 pre-filled syringes. 
Zdravilo BUCCOLAM je na voljo v škatlah, ki vsebujejo 4 napolnjene brizge.
Hold the plastic tube, break the seal at one end and pull the cap off. Take the syringe out of the tube. 
Primite plastični ovitek, prelomite pečat na enem koncu in odstranite pokrovček.
Do not give more than the amount of medicine prescribed by a doctor for the patient. 
Bolniku ne dajte večjega odmerka, kot mu ga je predpisal zdravnik.
How to store BUCCOLAM Contents of the pack and other information 
Shranjevanje zdravila BUCCOLAM Vsebina pakiranja in dodatne informacije
Following oromucosal administration in children the area under the curve ratio for alpha-hydroxy midazolam to midazolam is 0.46. 
Po oralnem dajanju otrokom je razmerje površine pod krivuljo med alfa-hidroksi-midazolamom in midazolamom 0,46.
Midazolam is excreted in low quantities (0.6%) in human milk. 
Midazolam se v majhnih količinah (0,6 %) izloča v materino mleko.
It also exerts a sedative and sleepinducing effect of pronounced intensity, and an anxiolytic and a muscle-relaxant effect. 
Deluje tudi močno sedativno in uspavalno, kakor tudi anksiolitično in kot mišični relaksant.
• You're unable to empty the syringe or you spill some of the contents 
o ne morete izprazniti brizge ali se vam razlije del vsebine;
The administration of high doses of midazolam in the last trimester of pregnancy or during labour has been reported to produce maternal or foetal adverse reactions (risk of aspiration of fluids and stomach contents during labour in the mother, irregularities in the foetal heart rate, hypotonia, poor suckling, hypothermia and respiratory depression in the new-born infant). 
Poročajo, da je dajanje visokih odmerkov midazolama v zadnjem trimesečju nosečnosti ali med porodom povzročilo neželene dogodke za mater ali plod (tveganje aspiracije tekočine in vsebine želodca med porodom pri materi, nepravilnosti srčnega utripa pri plodu, hipotonijo, slabo sesanje, hipotermijo in respiratorno depresijo pri novorojencih).
BUCCOLAM may increase the effect of some muscle relaxants e.g. baclofen (causing increased drowsiness). 
Zdravilo BUCCOLAM lahko zveča učinek nekaterih mišičnih relaksantov, npr. baklofena (ki zvečuje zaspanost).
Fatigue**, hiccups** **These adverse reactions have been reported to occur when midazolam is injected in children and/or adults, which may be of relevance to oromucosal administration. 
Zelo redki: utrujenost**, kolcanje** **Poročali so, da se ti neželeni učinki pojavljajo ob injiciranju midazolama otrokom in/ali odraslim, kar je morda pomembno za oralno dajanje.
• Heart attack. 
• srčni infarkt.
PHARMACEUTICAL FORM AND CONTENTS Oromucosal solution 
FARMACEVTSKA OBLIKA IN VSEBINA oralna raztopina
• antibiotics, e.g. erythromycin, clarithromycin 
• antibiotiki, npr. eritromicin, klaritromicin,